Stonepine Capital Management, LLC
CIK 1440771 · View on SEC EDGAR ↗
- Portfolio value
- $177.3M
- Positions
- 87
- As of
- June 30, 2026
#6,869 of 9,443 by 13F value · top 72.7%
Portfolio value QoQ: -29.0% 13F does not disclose cash
- Top 10 holdings weight
- 44.39%
- Top 25 holdings weight
- 73.95%
- Positions above 1%
- 29
- Effective number of positions
- 34.1
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 28.47% Est. buys $60,773,415 · sells $146,049,602
Median holding: 2.0 quarters Tracked Q4 2024–Q2 2026 · 45.1% still held
- New positions
- 25
- Increased
- 23
- Decreased
- 27
- Closed
- 13
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- High-conviction bets The holdings this manager is most concentrated in.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
- Related The person behind this filer, where we can match one.
Performance vs S&P 500
Annualized: +26.7% · S&P 500: +21.7%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 98.5% · Options excluded: 24.0%
Sector breakdown
Healthcare
92.0%
Other/Unmapped
8.0%
Full portfolio 87 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| VSTM Verastem, Inc. - Common Stock | $12,795,575 | 7.22% | 3,349,627 | $-4,706,615 | Up ×5 | ||
| EOLS Evolus, Inc. - Common Stock | $11,035,724 | 6.23% | 1,590,162 | $3,805,860 | Down ×1 | ||
| TENX Tenax Therapeutics, Inc. - Common Stock | $9,603,000 | 5.42% | 660,000 | $-5,990,448 | Down ×1 | ||
| NKTR Nektar Therapeutics - Common Stock | $8,422,856 | 4.75% | 120,654 | $2,307,106 | Up ×1 | ||
| ADMA ADMA Biologics Inc - Common Stock | $7,950,000 | 4.48% | 650,000 | Call option | $-2,411,500 | Down ×1 | |
| ADMA ADMA Biologics Inc - Common Stock | $6,193,800 | 3.49% | 740,000 | $-473,600 | |||
| CAMP CAMP4 Therapeutics Corporation - Common Stock | $6,072,648 | 3.43% | 1,389,622 | $-55,585 | |||
| INSM Insmed Incorporated - Common Stock | $5,600,000 | 3.16% | 40,000 | Call option | Up ×1 | ||
| Unknown issuer (CUSIP: 29014R301) | $5,512,581 | 3.11% | 397,160 | Up ×1 | |||
| RARE Ultragenyx Pharmaceutical Inc. - Common Stock | $5,500,000 | 3.10% | 200,000 | Call option | |||
| KZIA Kazia Therapeutics Limited - American Depositary Shares | $4,860,120 | 2.74% | 345,179 | $2,291,988 | |||
| MDT Medtronic plc. Ordinary Shares | $4,375,000 | 2.47% | 50,000 | Call option | Up ×1 | ||
| INDV Indivior Pharmaceuticals, Inc. - Common Stock | $4,103,000 | 2.31% | 100,000 | Up ×1 | |||
| CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | $3,986,500 | 2.25% | 425,000 | $385,792 | Up ×1 | ||
| ABT Abbott Laboratories Common Stock | $3,800,000 | 2.14% | 40,000 | Call option | Up ×1 | ||
| MSLE Satellos Bioscience Inc. - Common Stock | $3,723,291 | 2.10% | 491,624 | $3,160,291 | Up ×1 | ||
| ZVRA Zevra Therapeutics, Inc. - Common Stock | $3,709,772 | 2.09% | 258,701 | $-763,828 | Down ×3 | ||
| ABEO Abeona Therapeutics Inc. - Common Stock | $3,444,015 | 1.94% | 557,284 | $99,305 | Down ×1 | ||
| BSX Boston Scientific Corporation Common Stock | $3,250,000 | 1.83% | 50,000 | Call option | Up ×1 | ||
| EDSA Edesa Biotech, Inc. - Common Shares | $3,190,807 | 1.80% | 456,439 | $3,033,907 | Up ×1 | ||
| EOLS Evolus, Inc. - Common Stock | $3,150,000 | 1.78% | 420,000 | Call option | $1,423,800 | ||
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $3,125,000 | 1.76% | 50,000 | Call option | Up ×1 | ||
| CABA Cabaletta Bio, Inc. - Common Stock | $2,852,181 | 1.61% | 917,100 | $2,717,681 | Up ×1 | ||
| ANTX AN2 Therapeutics, Inc. - Common Stock | $2,670,190 | 1.51% | 551,692 | $228,840 | Down ×1 | ||
| Unknown issuer (CUSIP: 98422T209) | $2,165,023 | 1.22% | 225,994 | $1,625,421 | Up ×1 | ||
| ACET Adicet Bio, Inc. - Common Stock | $2,121,276 | 1.20% | 245,518 | $609,762 | Up ×2 | ||
| XERS Xeris Biopharma Holdings, Inc. - Common Stock | $2,100,000 | 1.18% | 280,000 | Call option | $476,000 | ||
| TELA TELA Bio, Inc. - Common stock | $1,996,820 | 1.13% | 2,662,427 | $374,124 | Up ×5 | ||
| AYTU Aytu BioPharma, Inc. - Common Stock | $1,962,780 | 1.11% | 912,921 | $-200,169 | Up ×1 | ||
| CRIS Curis, Inc. - Common Stock | $1,729,292 | 0.98% | 3,312,185 | $-310,170 | Down ×1 | ||
| SPRB Spruce Biosciences, Inc. - Common Stock | $1,554,930 | 0.88% | 28,795 | ||||
| HRTX Heron Therapeutics, Inc. - Common Stock | $1,500,000 | 0.85% | 1,000,000 | Call option | $699,900 | ||
| SIBN SI-BONE, Inc. - Common Stock | $1,500,000 | 0.85% | 100,000 | Call option | $237,000 | ||
| OKYO OKYO Pharma Limited - Ordinary Shares | $1,294,494 | 0.73% | 862,996 | $-74,006 | Up ×1 | ||
| NMRA Neumora Therapeutics, Inc. - Common Stock | $1,250,000 | 0.71% | 500,000 | Call option | $275,000 | ||
| KTTA Pasithea Therapeutics Corp. - Common Stock | $1,134,637 | 0.64% | 2,201,468 | $517,978 | Up ×2 | ||
| SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | $1,072,732 | 0.61% | 14,469 | $-1,127,841 | Down ×1 | ||
| LUNG Pulmonx Corporation - Common Stock | $1,060,067 | 0.60% | 815,436 | $68,975 | Up ×2 | ||
| XFOR X4 Pharmaceuticals, Inc. - Common Stock | $1,050,699 | 0.59% | 224,989 | $-334,127 | Down ×3 | ||
| ARDX Ardelyx, Inc. - Common Stock | $1,050,000 | 0.59% | 150,000 | Call option | $151,500 | ||
| DCTH Delcath Systems, Inc. - Common Stock | $1,000,000 | 0.56% | 100,000 | Call option | $72,000 | ||
| INAB IN8bio, Inc. - Common Stock | $980,355 | 0.55% | 695,287 | $-1,495 | Up ×4 | ||
| MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | $973,500 | 0.55% | 50,000 | Up ×1 | |||
| QNRX Quoin Pharmaceuticals, Ltd. - American Depositary Shares | $965,512 | 0.54% | 199,486 | $612,676 | Up ×1 | ||
| MXCT MaxCyte, Inc. - Common Stock | $924,475 | 0.52% | 751,606 | $218,692 | Down ×1 | ||
| PHAT Phathom Pharmaceuticals, Inc. - Common Stock | $922,358 | 0.52% | 85,010 | $366,747 | Up ×1 | ||
| AZTR | $886,903 | 0.50% | 5,285,476 | Up ×1 | |||
| CNTB Connect Biopharma Holdings Limited - Ordinary Shares | $866,925 | 0.49% | 364,254 | $54,725 | Up ×1 | ||
| HELP Cybin Inc. - Common Stock | $854,541 | 0.48% | 129,280 | $211,053 | Down ×2 | ||
| RARE Ultragenyx Pharmaceutical Inc. - Common Stock | $834,750 | 0.47% | 25,000 | ||||
| IKT Inhibikase Therapeutics, Inc. - Common Stock | $804,243 | 0.45% | 396,179 | $-803,856 | Down ×2 | ||
| ZNTL Zentalis Pharmaceuticals, Inc. - common stock | $783,678 | 0.44% | 161,583 | $153,984 | Down ×2 | ||
| CTMX CytomX Therapeutics, Inc. - Common Stock | $768,750 | 0.43% | 205,000 | $-171,250 | Up ×1 | ||
| MNKD MannKind Corporation - Common Stock | $750,000 | 0.42% | 250,000 | Call option | $-475,000 | Down ×1 | |
| NVCT Nuvectis Pharma, Inc. - Common Stock | $735,600 | 0.41% | 40,000 | Up ×1 | |||
| CBIO Crescent Biopharma, Inc. - Common Stock | $720,000 | 0.41% | 40,000 | $-841,450 | Down ×2 | ||
| PMVP PMV Pharmaceuticals, Inc. - Common Stock | $718,355 | 0.41% | 536,086 | $-159,691 | Down ×3 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $713,775 | 0.40% | 7,500 | Up ×1 | |||
| RADX Radiopharm Theranostics Limited - American Depositary Shares | $670,500 | 0.38% | 51,000,000 | $-68,477 | |||
| OKUR OnKure Therapeutics, Inc. - Class A Common Stock | $595,919 | 0.34% | 130,684 | $47,046 | Down ×1 | ||
| NGEN NervGen Pharma Corp. - Common stock | $559,657 | 0.32% | 271,678 | Up ×1 | |||
| CALC CalciMedica, Inc. - Common Stock | $544,939 | 0.31% | 622,432 | ||||
| ARVN Arvinas, Inc. - Common Stock | $498,600 | 0.28% | 60,000 | $207,100 | Up ×1 | ||
| BIOA BioAge Labs, Inc. - Common Stock | $490,200 | 0.28% | 20,000 | $-384,300 | Down ×1 | ||
| IRD Opus Genetics, Inc. - Common Stock | $413,951 | 0.23% | 100,718 | $101,421 | Up ×1 | ||
| QTI QT Imaging Holdings, Inc. - Common Stock | $407,000 | 0.23% | 100,000 | Up ×1 | |||
| BOLD Boundless Bio, Inc. - Common Stock | $386,488 | 0.22% | 154,595 | $-270,962 | Down ×2 | ||
| SINT SiNtx Technologies, Inc. - Common Stock | $332,531 | 0.19% | 209,205 | Up ×1 | |||
| CLRB Cellectar Biosciences, Inc. - Common Stock | $290,649 | 0.16% | 104,550 | Up ×1 | |||
| EPRX Eupraxia Pharmaceuticals Inc. - Common Stock | $287,476 | 0.16% | 43,491 | Up ×1 | |||
| SABS SAB Biotherapeutics, Inc. - Common Stock | $285,757 | 0.16% | 73,271 | $94,257 | Up ×1 | ||
| ANL Adlai Nortye Ltd. - American Depositary Shares | $278,956 | 0.16% | 24,257 | Up ×1 | |||
| SENS Senseonics Holdings, Inc. - Common Stock | $276,502 | 0.16% | 48,680 | Up ×1 | |||
| PLRX Pliant Therapeutics, Inc. - Common Stock | $262,813 | 0.15% | 230,538 | $-20,246 | Up ×1 | ||
| CDXS Codexis, Inc. - Common Stock | $247,836 | 0.14% | 109,662 | $-433,494 | Down ×1 | ||
| POCI Precision Optics Corporation, Inc. - Common stock | $236,589 | 0.13% | 46,390 | $-202,411 | Down ×1 | ||
| UPB Upstream Bio, Inc. - Common Stock | $231,349 | 0.13% | 33,432 | $-83,651 | Down ×1 | ||
| RNTX Rein Therapeutics, Inc. - Common Stock | $226,760 | 0.13% | 218,038 | Up ×1 | |||
| HRTX Heron Therapeutics, Inc. - Common Stock | $209,468 | 0.12% | 490,787 | $-912,425 | Down ×1 | ||
| CNSP CNS Pharmaceuticals, Inc. - Common Stock | $198,719 | 0.11% | 41,573 | $52,929 | Down ×1 | ||
| HUMA Humacyte, Inc. - Common Stock | $180,506 | 0.10% | 231,299 | Up ×1 | |||
| KLRS Kalaris Therapeutics, Inc. - Common Stock | $122,597 | 0.07% | 30,122 | $4,889 | Up ×1 | ||
| PCSA Processa Pharmaceuticals, Inc. - Common Stock | $105,600 | 0.06% | 55,000 | $-33,275 | |||
| Unknown issuer (CUSIP: 09077B203) | $68,028 | 0.04% | 16,432 | Up ×1 | |||
| CGEN Compugen Ltd. - Ordinary Shares | $67,168 | 0.04% | 31,387 | $-154,991 | Down ×2 | ||
| OVID Ovid Therapeutics Inc. - Common Stock | $57,297 | 0.03% | 21,300 | $-31,503 | Down ×2 | ||
| EVAX Evaxion A/S - American Depositary Share | $54,442 | 0.03% | 17,562 | $-18,890 | Down ×2 | ||
| No matches | |||||||
Conviction holdings
Positions increased for 3+ consecutive quarters.
Share counts are as reported in 13F filings (not split-adjusted)
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| INSM | $5,600,000 | 40,000 | 3.16% |
| Unknown issuer (CUSIP: 29014R301) | $5,512,581 | 397,160 | 3.11% |
| RARE | $5,500,000 | 200,000 | 3.10% |
| MDT | $4,375,000 | 50,000 | 2.47% |
| INDV | $4,103,000 | 100,000 | 2.31% |
| ABT | $3,800,000 | 40,000 | 2.14% |
| BSX | $3,250,000 | 50,000 | 1.83% |
| BMRN | $3,125,000 | 50,000 | 1.76% |
| SPRB | $1,554,930 | 28,795 | 0.88% |
| MLTX | $973,500 | 50,000 | 0.55% |
| AZTR | $886,903 | 5,285,476 | 0.50% |
| RARE | $834,750 | 25,000 | 0.47% |
| NVCT | $735,600 | 40,000 | 0.41% |
| ORKA | $713,775 | 7,500 | 0.40% |
| NGEN | $559,657 | 271,678 | 0.32% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| TENX | Trimmed | -315K | -$6.0M |
| VSTM | Bought more | +47K | -$4.7M |
| EOLS | Trimmed | -169K | +$3.8M |
| ADMA | Trimmed | -500K | -$2.4M |
| NKTR | Bought more | +36K | +$2.3M |
| KZIA | Price move only | +0 | +$2.3M |
| — | Bought more | +162K | +$1.6M |
| EOLS | Price move only | +0 | +$1.4M |
| SLGL | Trimmed | -13K | -$1.1M |
| CBIO | Trimmed | -45K | -$841K |
4 positions hidden (data completeness check)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| XBI | June 30, 2026 | 800,000 | $102,184,000 | No longer tracked |
| OPTN | June 30, 2025 | 788,647 | $7,231,893 | No longer tracked |
| TERN | June 30, 2026 | 100,000 | $5,272,000 | No longer tracked |
| URGN | June 30, 2025 | 333,400 | $3,687,404 | 258.4% |
| INDV | March 31, 2026 | 100,000 | $3,588,000 | 26.4% |
| ESTA | June 30, 2026 | 56,000 | $3,179,680 | -12.8% |
| ITOS | Sept. 30, 2025 | 310,033 | $3,091,029 | No longer tracked |
| AQST | June 30, 2025 | 200,000 | $3,039,973 | 37.5% |
| IRWD | March 31, 2025 | 648,785 | $2,874,118 | 188.4% |
| CRSP | March 31, 2026 | 50,000 | $2,622,000 | 20.9% |
| ANIP | Sept. 30, 2025 | 38,597 | $2,518,454 | -14.9% |
| GLPG | June 30, 2025 | 93,968 | $2,360,476 | No longer tracked |
| ARE | June 30, 2026 | 50,000 | $2,321,000 | -4.2% |
| RARE | March 31, 2026 | 100,000 | $2,300,000 | 26.8% |
| ACAD | June 30, 2026 | 100,000 | $2,226,000 | 17.7% |
| XOMA | June 30, 2026 | 69,500 | $2,180,215 | No longer tracked |
| ANIK | Sept. 30, 2025 | 190,590 | $2,016,442 | 126.2% |
| DAWN | March 31, 2026 | 200,000 | $1,864,000 | No longer tracked |
| SPRB | March 31, 2026 | 19,742 | $1,719,726 | -21.3% |
| EDSA | June 30, 2025 | 687,500 | $1,677,500 | 148.8% |
| SLNO | Dec. 31, 2025 | 24,000 | $1,622,400 | No longer tracked |
| ENTA | March 31, 2026 | 100,000 | $1,577,000 | 6.8% |
| MIST | March 31, 2026 | 662,666 | $1,338,585 | -8.0% |
| YMAB | Sept. 30, 2025 | 285,300 | $1,286,703 | No longer tracked |
| JAZZ | March 31, 2025 | 10,000 | $1,231,500 | 102.4% |
| COLL | Sept. 30, 2025 | 41,500 | $1,227,155 | -18.8% |
| ALMS | Dec. 31, 2025 | 300,000 | $1,197,000 | 142.2% |
| KALV | Sept. 30, 2025 | 100,000 | $1,130,500 | No longer tracked |
| ARDX | Dec. 31, 2025 | 200,000 | $1,102,000 | -31.0% |
| DVAX | Dec. 31, 2025 | 108,094 | $1,073,373 | No longer tracked |
| GERN | March 31, 2026 | 805,800 | $1,063,656 | 5.0% |
| KROS | June 30, 2025 | 100,000 | $1,019,000 | -19.3% |
| MYO | Sept. 30, 2025 | 457,419 | $988,025 | No longer tracked |
| KZR | March 31, 2026 | 156,179 | $982,366 | No longer tracked |
| VNDA | Dec. 31, 2025 | 195,000 | $973,050 | -38.5% |
| SRZN | June 30, 2026 | 33,005 | $961,436 | -8.1% |
| XERS | Sept. 30, 2025 | 205,100 | $957,817 | 9.7% |
| SCPH | June 30, 2025 | 347,687 | $914,417 | No longer tracked |
| VIR | Dec. 31, 2025 | 160,000 | $913,600 | 57.2% |
| TSVT | March 31, 2025 | 300,000 | $882,000 | No longer tracked |
| INO | June 30, 2025 | 518,331 | $844,880 | -38.3% |
| PROF | June 30, 2025 | 139,942 | $814,462 | 20.2% |
| SMLR | March 31, 2026 | 50,000 | $764,500 | No longer tracked |
| ACHV | Sept. 30, 2025 | 333,333 | $753,333 | 163.8% |
| THRD | June 30, 2025 | 212,783 | $738,357 | No longer tracked |
| ANGO | Dec. 31, 2025 | 60,000 | $670,200 | 24.9% |
| GOSS | March 31, 2026 | 204,770 | $634,787 | -52.8% |
| GRCE | Dec. 31, 2025 | 211,010 | $628,177 | -35.8% |
| LQDA | Sept. 30, 2025 | 50,000 | $623,000 | 220.6% |
| SNDX | Dec. 31, 2025 | 37,200 | $572,322 | -3.2% |
| AQST | Dec. 31, 2025 | 100,600 | $562,354 | -29.6% |
| VRCA | June 30, 2026 | 99,735 | $527,598 | -18.3% |
| CADL | June 30, 2026 | 102,500 | $502,250 | 29.3% |
| SPRO | Sept. 30, 2025 | 156,888 | $454,975 | -33.5% |
| HLVX | Sept. 30, 2025 | 226,009 | $449,758 | No longer tracked |
| THTX | Sept. 30, 2025 | 189,051 | $446,160 | No longer tracked |
| HCAT | Dec. 31, 2025 | 155,551 | $443,320 | -28.9% |
| ESTA | Dec. 31, 2025 | 10,585 | $433,879 | 2.7% |
| SLRN | June 30, 2025 | 167,580 | $413,923 | No longer tracked |
| CTMX | Dec. 31, 2025 | 125,000 | $398,750 | -17.8% |
| NBP | June 30, 2025 | 483,647 | $398,477 | -24.1% |
| SEPN | June 30, 2025 | 68,084 | $394,206 | 309.1% |
| FENC | March 31, 2026 | 50,000 | $385,000 | 90.4% |
| RZLT | Dec. 31, 2025 | 40,000 | $376,000 | 97.5% |
| ACRS | Dec. 31, 2025 | 192,900 | $366,510 | 112.6% |
| XGN | June 30, 2025 | 95,747 | $343,732 | 9.0% |
| HSDT | Dec. 31, 2025 | 20,000 | $297,800 | -35.6% |
| JANX | June 30, 2026 | 20,000 | $278,000 | 13.2% |
| RNXT | June 30, 2025 | 278,188 | $275,406 | -2.7% |
| ANTX | March 31, 2025 | 196,732 | $271,490 | 334.2% |
| KPRX | March 31, 2026 | 131,144 | $258,354 | 34.7% |
| OABI | June 30, 2026 | 164,045 | $257,551 | 81.1% |
| TNYA | March 31, 2026 | 352,001 | $250,449 | 3.8% |
| SVRA | Dec. 31, 2025 | 60,000 | $214,200 | -8.0% |
| ABVX | Dec. 31, 2025 | 2,500 | $212,250 | -12.8% |
| ACET | June 30, 2025 | 508,266 | $203,500 | 1481.4% |
| CRGX | June 30, 2025 | 50,000 | $203,500 | No longer tracked |
| MIST | June 30, 2025 | 250,000 | $200,025 | -43.6% |
| CRBP | June 30, 2025 | 35,000 | $185,850 | 42.8% |
| NUVB | Sept. 30, 2025 | 85,300 | $166,335 | 90.0% |
| PYPD | June 30, 2025 | 54,975 | $148,982 | 41.6% |
| KURA | Sept. 30, 2025 | 25,000 | $144,250 | 37.6% |
| CLYM | Sept. 30, 2025 | 116,147 | $144,022 | 752.2% |
| CALC | Sept. 30, 2025 | 85,000 | $136,000 | -81.3% |
| GLUE | Sept. 30, 2025 | 30,000 | $135,300 | 104.5% |
| ELEV | March 31, 2025 | 200,000 | $112,520 | No longer tracked |
| ABVX | March 31, 2025 | 15,000 | $109,800 | 1782.2% |
| ELDN | June 30, 2026 | 35,000 | $107,800 | -10.4% |
| AMRNXXXX | June 30, 2025 | 651,614 | $105,000 | No longer tracked |
| ELAN | June 30, 2025 | 10,000 | $105,000 | 69.6% |
| WHWK | June 30, 2025 | 46,698 | $83,122 | 157.8% |
| XLO | March 31, 2026 | 126,270 | $80,838 | 11.9% |
| LRMR | Dec. 31, 2025 | 25,000 | $80,750 | 8.0% |
| CMMB | Dec. 31, 2025 | 30,000 | $78,900 | 27.0% |
| ALLR | March 31, 2025 | 67,289 | $78,728 | 53.7% |
| RVNC | March 31, 2025 | 23,264 | $70,723 | No longer tracked |
| WHWK | Dec. 31, 2025 | 35,253 | $66,981 | 99.2% |
| IOVA | June 30, 2025 | 20,000 | $66,600 | 380.8% |
| JSPR | Dec. 31, 2025 | 20,200 | $48,076 | -59.2% |
| CHRS | Sept. 30, 2025 | 62,700 | $45,853 | -20.4% |
| EBS | June 30, 2025 | 5,000 | $24,300 | -25.2% |
| NKTX | June 30, 2025 | 10,000 | $18,400 | 51.2% |
| APRE | June 30, 2025 | 102,242 | $14,400 | -60.2% |
| ESPR | June 30, 2025 | 10,000 | $14,400 | No longer tracked |
| BCAB | June 30, 2026 | 65,387 | $10,527 | -19.8% |